The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants

New England Journal of Medicine

Volumn 337, Issue 7, 1997, Pages 466-471

  Shankaran, Seetha ^a,m   Papile, Lu Ann ^b   Wright, Linda L ^c   Ehrenkranz, Richard A ^d   Mele, Lisa ^e   Lemons, James A ^f   Korones, Sheldon B ^g   Stevenson, David K ^h   Donovan, Edward F ⁱ   Stoll, Barbara J ^j   Fanaroff, Avroy A ^k   Oh, William ^l   Verter, Joel ⁿ   Taylor, George A ^e   Seibert, JoAnna ^o   DiPietro, Michael ^p  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d YALE UNIVERSITY   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

^j EMORY UNIVERSITY   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l WOMEN AND INFANTS HOSPITAL   (United States)

^m CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

ⁿ HARVARD UNIVERSITY   (United States)

^o UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^p UNIVERSITY OF MICHIGAN   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; PLACEBO;

ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EARLY DIAGNOSIS; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NEWBORN; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT;

ADULT; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; ODDS RATIO; PHENOBARBITAL; PREGNANCY; PRENATAL CARE; TREATMENT OUTCOME;

EID: 0030841377     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199708143370705     Document Type: Article

References (20)

1. Horbar JD. Prevention of periventricular-intraventricular hemorrhage. In: Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. Oxford, England: Oxford University Press, 1992:562-89.
2. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93:543-50.
3. Shaver DC, Bada HS, Korones SB, Anderson GD, Wong SP, Arheart KL. Early and late intraventricular hemorrhage: the role of obstetric factors. Obstet Gynecol 1992;80:831-7.
4. Paneth N, Pinto-Martin J, Gardiner J, et al. Incidence and timing of germinal matrix/intraventricular hemorrhage in low birth weight infants. Am J Epidemiol 1993;137:1167-76.
5. Shankaran S, Cepeda EE, Ilagan N, et al. Antenatal phenobarbital for the prevention of neonatal intracerebral hemorrhage. Am J Obstet Gynecol 1986;154:53-7.
6. Morales WJ, Koerten J. Prevention of intraventricular hemorrhage in very low birth weight infants by maternally administered phenobarbital. Obstet Gynecol 1986;68:295-9.
7. De Carolis S, De Carolis MP, Caruso A, et al. Antenatal phenobarbital in preventing intraventricular hemorrhage in premature newborns. Fetal Ther 1988;3:224-9.
8. Kaempf JW, Porreco R, Molina R, Hale K, Pantoja AF, Rosenberg AA. Antenatal phenobarbital for the prevention of periventricular and intraventricular hemorrhage: a double-blind, randomized, placebo-controlled, multihospital trial. J Pediatr 1990;117:933-8.
9. Shankaran S, Cepeda E, Muran G, et al. Antenatal phenobarbital therapy and neonatal outcome. I. Effect on intracranial hemorrhage. Pediatrics 1996;97:644-8.
10. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials 1988;9:345-64. [Erratum, Control Clin Trials 1989;10:126a.]
11. Shankaran S, Cepeda EE, Ilagan N, Kauffman RE. Pharmacokinetic basis for antenatal dosing of phenobarbital for the prevention of neonatal intracerebral hemorrhage. Dev Pharmacol Ther 1986;9:171-7.
12. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
13. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
14. Lan KKG, Simon R, Halperin M. Stochastically curtailed tests in long term clinical trials. Commun Stat Sequential Anal 1982;1:207-19.
15. Wimberley PD, Lou HC, Pedersen H, Hejl M, Lassen NA, Friis-Hansen B. Hypertensive peaks in the pathogenesis of intraventricular hemorrhage in the newborn: abolition by phenobarbitone sedation. Acta Paediatr Scand 1982;71:537-42.
16. Goddard-Finegold J, Armstrong DL. Reduction in incidence of periventricular, intraventricular hemorrhages in hypertensive newborn beagles pretreated with phenobarbital. Pediatrics 1987;79:901-6.
17. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus statement. Vol. 12. No. 2. Bethesda, Md.: NIH Office of Medical Applications of Research, 1994:1-24.
18. Shankaran S, Bauer CR, Bain R, Wright LL, Zachary J. Prenatal and perinatal risk and protective factors for neonatal intracranial hemorrhage. Arch Pediatr Adoles Med 1996;150:491-7.
19. Thorp JA, Ferrette-Smith D, Gaston LA, Johnson J, Yeast JD, Meyer B. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation. Obstet Gynecol 1995;86:1-8.
20. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995;346: 1271-9. [Erratum, Lancet 1996;347:410.]